Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment”

Detalles Bibliográficos
Autores principales: Brooks, Anne B., Langer, Jakob, Tervonen, Tommi, Peter Hemmingsen, Mads, Eguchi, Kosei, Bacci, Elizabeth D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509018/
https://www.ncbi.nlm.nih.gov/pubmed/32767278
http://dx.doi.org/10.1007/s13300-020-00900-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509018/
https://www.ncbi.nlm.nih.gov/pubmed/32767278
http://dx.doi.org/10.1007/s13300-020-00900-3

Ejemplares similares